Orange Book product · Brand (NDA)
HYDROMORPHONE HYDROCHLORIDE
HYDROMORPHONE HYDROCHLORIDE
At a glance
Dec 14, 2023
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 14, 2023
2 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROMORPHONE HYDROCHLORIDE
Strength
40MG/20ML (2MG/ML)
Dosage form
SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
TE code
Not listed
Application
NDA 217812
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023HYDROMORPHONE HYDROCHLORIDEBrand (NDA)
NDA 200403 · HOSPIRA INC
- 2020DILAUDIDBrand (NDA)
NDA 019034 · FRESENIUS KABI USA
- 2010EXALGOBrand (NDA)
NDA 021217 · SPECGX LLC
- 2007DILAUDIDBrand (NDA)
NDA 019892 · RHODES PHARMS
- 2004PALLADONEBrand (NDA)
NDA 021044 · PURDUE PHARMA LP
- 1992DILAUDIDBrand (NDA)
NDA 019891 · RHODES PHARMS
- 2024HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 216899 · HIKMA
- 2020HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 212133 · ASCENT PHARMS INC
- 2020HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 207108 · GENUS
- 2018HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 202159 · HIKMA
- 2018HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 210506 · ASCENT PHARMS INC
- 2017HYDROMORPHONE HYDROCHLORIDEGeneric (ANDA)
ANDA 210176 · ASCENT PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
